edoc

Items where Author is "Ioannidis, John P. A."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2021 | 2020 | 2019 | 2018 | January 2017
Number of items: 12.

2021

Mc Cord, Kimberly A. and Ewald, Hannah and Agarwal, Arnav and Glinz, Dominik and Aghlmandi, Soheila and Ioannidis, John P. A. and Hemkens, Lars G.. (2021) Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials: meta-research study. BMJ, 372. n450.

2020

Ladanie, Aviv and Schmitt, Andreas M. and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Herbrand, Amanda K. and Briel, Matthias and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2020) Clinical trial evidence supporting US Food and Drug Administration approval of novel cancer therapies between 2000 and 2016. Jama Network Open, 3 (11). e2024406.

Kasenda, Benjamin and Liu, Junhao and Jiang, Yu and Gajewski, Byron and Wu, Cen and von Elm, Erik and Schandelmaier, Stefan and Moffa, Giusi and Trelle, Sven and Schmitt, Andreas Michael and Herbrand, Amanda K. and Gloy, Viktoria and Speich, Benjamin and Hopewell, Sally and Hemkens, Lars G. and Sluka, Constantin and McGill, Kris and Meade, Maureen and Cook, Deborah and Lamontagne, Francois and Tréluyer, Jean-Marc and Haidich, Anna-Bettina and Ioannidis, John P. A. and Treweek, Shaun and Briel, Matthias. (2020) Prediction of RECRUITment In Randomized Clinical Trials (RECRUIT-IT) - Rationale and Design for an International Collaborative Study. Trials, 21. p. 731.

Janiaud, Perrine and Axfors, Cathrine and Van't Hooft, Janneke and Saccilotto, Ramon and Agarwal, Arnav and Appenzeller-Herzog, Christian and Contopoulos-Ioannidis, Despina G. and Danchev, Valentin and Dirnagl, Ulrich and Ewald, Hannah and Gartlehner, Gerald and Goodman, Steven N. and Haber, Noah A. and Ioannidis, Angeliki Diotima and Ioannidis, John P. A. and Lythgoe, Mark P. and Ma, Wenyan and Macleod, Malcolm and Malički, Mario and Meerpohl, Joerg J. and Min, Yan and Moher, David and Nagavci, Blin and Naudet, Florian and Pauli-Magnus, Christiane and O'Sullivan, Jack W. and Riedel, Nico and Roth, Jan A. and Sauermann, Mandy and Schandelmaier, Stefan and Schmitt, Andreas M. and Speich, Benjamin and Williamson, Paula R. and Hemkens, Lars G.. (2020) The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days. F1000Research, 9. p. 1193.

2019

Mastellos, Dimitrios C. and Blom, Anna M. and Connolly, E. Sander and Daha, Mohamed R. and Geisbrecht, Brian V. and Ghebrehiwet, Berhane and Gros, Piet and Hajishengallis, George and Holers, V. Michael and Huber-Lang, Markus and Kinoshita, Taroh and Mollnes, Tom E. and Montgomery, Robert A. and Morgan, B. Paul and Nilsson, Bo and Pio, Ruben and Ricklin, Daniel and Risitano, Antonio M. and Taylor, Ronald P. and Mantovani, Alberto and Ioannidis, John P. A. and Lambris, John D.. (2019) 'Stealth' corporate innovation: an emerging threat for therapeutic drug development. Nature immunology, 20 (11). pp. 1409-1413.

Ewald, Hannah and Speich, Benjamin and Ladanie, Aviv and Bucher, Heiner C. and Ioannidis, John P. A. and Hemkens, Lars G.. (2019) Marginal structural models and other analyses allow multiple estimates of treatment effects in randomized clinical trials: Meta-epidemiological analysis. Journal of clinical epidemiology, 107. pp. 12-26.

Ewald, Hannah and Ioannidis, John P. A. and Ladanie, Aviv and Mc Cord, Kimberly and Bucher, Heiner C. and Hemkens, Lars G.. (2019) Nonrandomized studies using causal-modeling may give different answers than RCTs: a meta-epidemiological study. Journal of clinical epidemiology, 118. pp. 29-41.

Ladanie, Aviv and Speich, Benjamin and Briel, Matthias and Sclafani, Francesco and Bucher, Heiner C. and Agarwal, Arnav and Ioannidis, John P. A. and Pereira, Tiago V. and Kasenda, Benjamin and Hemkens, Lars G.. (2019) Single pivotal trials with few corroborating characteristics were used for FDA approval of cancer therapies. Journal of clinical epidemiology, 114. pp. 49-59.

2018

Ladanie, Aviv and Ioannidis, John P. A. and Stafford, Randall S. and Ewald, Hannah and Bucher, Heiner C. and Hemkens, Lars G. and Hemkens, Lars G.. (2018) Off-label prescription : experience is a gloomy lantern that does not even illuminate its bearer. Journal of clinical epidemiology, 101. pp. 127-128.

Ladanie, Aviv and Ioannidis, John P. A. and Stafford, Randall S. and Ewald, Hannah and Bucher, Heiner C. and Hemkens, Lars G.. (2018) Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials. Journal of clinical epidemiology, 94. pp. 35-45.

Ladanie, Aviv and Speich, Benjamin and Naudet, Florian and Agarwal, Arnav and Pereira, Tiago V. and Sclafani, Francesco and Martin-Liberal, Juan and Schmid, Thomas and Ewald, Hannah and Ioannidis, John P. A. and Bucher, Heiner C. and Kasenda, Benjamin and Hemkens, Lars G.. (2018) The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: rationale and design of the database and the collection of evidence available at approval of novel drugs. Trials, 19 (1). p. 505.

January 2017

Hemkens, Lars G. and Ewald, Hannah and Naudet, Florian and Ladanie, Aviv and Shaw, Jonathan G. and Sajeev, Gautam and Ioannidis, John P. A.. (2017) Interpretation of epidemiologic studies very often lacked adequate consideration of confounding. Journal of Clinical Epidemiology, 93. pp. 94-102.

This list was generated on Tue Mar 19 04:28:30 2024 CET.